Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.45%
1,082.80
+15.44
+1.45%
—1,067.361,073.631,085.941,073.63——
SIXC
Communications
SIXC
Communications
SIXC
+0.05%
603.77
+0.29
+0.05%
—603.48603.48606.47601.43——
SIXE
Energy
SIXE
Energy
SIXE
-2.71%
1,211.19
-33.74
-2.71%
—1,244.931,238.101,246.591,210.94——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.48%
1,755.99
+25.61
+1.48%
—1,730.381,737.301,760.621,737.30——
SIXM
Financials
SIXM
Financials
SIXM
-0.15%
638.51
-0.96
-0.15%
—639.47639.46643.01636.91——
SIXR
Staples
SIXR
Staples
SIXR
-1.40%
842.96
-11.99
-1.40%
—854.95854.97855.66842.13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.33%
219.28
+0.72
+0.33%
—218.56218.56220.16218.53——
SIXT
Technology
SIXT
Technology
SIXT
+2.66%
3,728.35
+96.76
+2.66%
—3,631.593,687.983,744.373,675.71——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.03%
915.48
-0.29
-0.03%
—915.77917.87921.16915.35——
SIXV
Health care
SIXV
Health care
SIXV
-1.02%
1,497.36
-15.45
-1.02%
—1,512.811,514.561,514.951,497.36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.21%
2,413.17
+4.96
+0.21%
—2,408.212,418.112,427.232,398.16——
MGX:NASDAQ
Metagenomi Therapeutics Inc
$1.36
+0.74%
(+0.0100) 1D
$1.35
-0.74% (-0.0100)
Pre-market
Closed: May 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MGX...
Open
$1.35
High
$1.37
Low
$1.28
Mkt. cap
51.20M
Avg. vol.
180.99K
Volume
2.51K
52-wk high
$3.95
52-wk low
$1.24
EPS
-$2.30
Shares outstanding
37.65M
No. of employees
118
News stories
From sources across the web
About Metagenomi Therapeutics Inc
CEO-
Employees118
Founded2016
HeadquartersEmeryville, California, United States
SectorBiotechnology
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.61 / -$0.55
-10.91%miss
Revenue / Est. (USD)
1.25M / 5.92M
-78.94%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.51M
8.66M
3.91M
1.25M
Cost of goods sold
22.51M
25.28M
21.50M
-
Cost of revenue
22.51M
25.28M
21.50M
-
Research and development expenses
-
-
-
19.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.99M
6.22M
6.78M
6.54M
Operating expense
6.99M
6.22M
6.78M
25.84M
Total operating expenses
29.50M
31.50M
28.28M
25.84M
Operating income
-20.99M
-22.84M
-24.37M
-24.59M
Other non operating income
-70.00K
-2.00K
-11.00K
-1.00K
EBT including unusual items
-19.86M
-20.63M
-22.49M
-23.05M
EBT excluding unusual items
-18.57M
-20.63M
-22.49M
-23.05M
Income tax expense
44.00K
-234.00K
34.00K
10.00K
Effective tax rate
-0.22%
1.13%
-0.15%
-0.04%
Other operating expenses
-
-
-
-
Net income
-19.91M
-20.39M
-22.53M
-23.06M
Net profit margin
-233.85%
-235.51%
-576.02%
-1,847.68%
Earnings per share
-0.54
-0.55
-0.60
-0.61
Interest and investment income
2.48M
2.21M
1.88M
1.54M
Interest expense
-
-
-
-
Net interest expenses
2.48M
2.21M
1.88M
1.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.65M
-21.52M
-23.07M
-23.31M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more